Holen Sie sich die Stockscreener-App
5.50
4.18%
-0.24
Handel nachbörslich:
5.41
-0.09
-1.64%
Schlusskurs vom Vortag:
$5.74
Offen:
$5.75
24-Stunden-Volumen:
65,309
Relative Volume:
0.80
Marktkapitalisierung:
$91.99M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.88M
KGV:
-5.6122
EPS:
-0.98
Netto-Cashflow:
$-10.29M
1W Leistung:
-9.09%
1M Leistung:
-7.41%
6M Leistung:
-14.73%
1J Leistung:
-11.58%
1-Tages-Spanne:
$5.50
$5.8622
1-Wochen-Bereich:
$5.37
$6.184
52-Wochen-Spanne:
$4.65
$10.24
Coya Therapeutics Inc Stock (COYA) Company Profile
Firmenname
Coya Therapeutics Inc
Sektor
Branche
Telefon
650.739.3939
Adresse
12645 MEMORIAL DR., SUITE F1 #305, HOUSTON
Vergleichen Sie COYA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COYA
Coya Therapeutics Inc
|
5.50 | 96.00M | 0 | -14.88M | -10.29M | -0.98 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Coya Therapeutics Inc Stock (COYA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-09 | Eingeleitet | Lake Street | Buy |
| 2024-12-04 | Eingeleitet | D. Boral Capital | Buy |
Coya Therapeutics Inc Aktie (COYA) Neueste Nachrichten
What earnings revisions data tells us about Coya Therapeutics Inc.Quarterly Earnings Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Can trapped investors hope for a rebound in Coya Therapeutics Inc.Weekly Investment Recap & Smart Money Movement Tracker - newser.com
Is Coya Therapeutics Inc. forming a bottoming baseMarket Trend Summary & High Accuracy Investment Signals - newser.com
Earnings Miss: How much upside does Coya Therapeutics Inc haveJuly 2025 Recap & AI Powered Market Entry Strategies - khodrobank.com
Weekly Recap: Is Coya Therapeutics Inc benefiting from innovation trendsPortfolio Risk Report & Risk Controlled Swing Alerts - khodrobank.com
Using RSI to spot recovery in Coya Therapeutics Inc.July 2025 Closing Moves & Technical Pattern Based Buy Signals - newser.com
MACD Signal: How do insiders feel about Coya Therapeutics IncShare Buyback & Free Low Drawdown Momentum Trade Ideas - khodrobank.com
Smart tools for monitoring Coya Therapeutics Inc.’s price action2025 Market Sentiment & Free Safe Capital Growth Stock Tips - newser.com
Movement Recap: Will Coya Therapeutics Inc outperform its industry peersDip Buying & AI Optimized Trading Strategy Guides - khodrobank.com
How to integrate Coya Therapeutics Inc. into portfolio analysis toolsJuly 2025 Update & Fast Entry High Yield Tips - newser.com
Analyst Calls: Should I buy Coya Therapeutics Inc stock now2025 AllTime Highs & Reliable Volume Spike Trade Alerts - khodrobank.com
Real time breakdown of Coya Therapeutics Inc. stock performance2025 Breakouts & Breakdowns & Technical Pattern Recognition Alerts - newser.com
Market Outlook: Is now the right time to enter Coya Therapeutics IncQuarterly Portfolio Review & Weekly High Return Forecasts - khodrobank.com
Coya Therapeutics (NASDAQ:COYA) Given "Buy" Rating at D. Boral Capital - MarketBeat
Coya Therapeutics (NASDAQ:COYA) Earns "Buy" Rating from Chardan Capital - MarketBeat
Coya Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Final Week & Real-Time Volume Spike Alerts - newser.com
Coya’s first results with COYA-303 in mouse model of inflammation - BioWorld MedTech
COYA: Analyst Jason Kolbert Maintains 'Buy' Rating with $18 Targ - GuruFocus
Top chart patterns to watch in Coya Therapeutics Inc.Dollar Strength & Stepwise Entry and Exit Trade Signals - newser.com
Coya Therapeutics Highlights Q2 2025 Financial Results - MSN
EXCLUSIVE: Coya Therapeutics Investigational Combination Therapy With GLP-1 Shows Potential For Alzheimer's Disease - AOL.com
Coya Therapeutics Says COYA 303 Shows Promising Anti-Inflammatory Effects in Preclinical Study - MarketScreener
Breakthrough: Novel Alzheimer's Drug COYA 303 Shows Dual Action in Brain Inflammation Control - Stock Titan
Earnings Miss: Can COSCIENS Biopharma Inc generate free cash flowOil Prices & Safe Entry Point Alerts - خودرو بانک
Can momentum traders help lift Coya Therapeutics Inc.2025 Geopolitical Influence & Advanced Technical Analysis Signals - newser.com
Is Coya Therapeutics Inc. a candidate for recovery play2025 EndofYear Setup & Intraday High Probability Alerts - newser.com
heatmap analysis for coya therapeutics inc. and competitorsOptions Play & Free Expert Verified Stock Movement Alerts - Newser
Statistical indicators supporting Coya Therapeutics Inc.’s strength2025 Technical Patterns & Consistent Income Trade Recommendations - Newser
Heatmap analysis for Coya Therapeutics Inc. and competitorsTreasury Yields & Free Real-Time Volume Trigger Notifications - Newser
Finanzdaten der Coya Therapeutics Inc-Aktie (COYA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.43%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):